Illumina Newswire

Illumina Newswire

Comprehensive Real-Time News Feed for Illumina.

Results 1 - 20 of 245 in Illumina

  1. Daniel Bradbury Sells 600 Shares of Illumina, Inc. (ILMN) StockRead the original story w/Photo

    23 hrs ago | IntersportsWire

    Illumina, Inc. Director Daniel Bradbury sold 600 shares of the stock in a transaction on Friday, February 17th. The shares were sold at an average price of $162.80, for a total transaction of $97,680.00.

    Comment?

  2. Illumina CEO brings entrepreneurial spirit to genomics giantRead the original story w/Photo

    Thursday | The San Diego Union-Tribune

    Illumina Inc. is the largest genomics company in the world. The DNA sequencers and related products from the San Diego biotech company have driven down the cost of sequencing a human genome to less than $1,000 each.

    Comment?

  3. Illumina, Inc. (ILMN) Shares Bought by Capital International Inc. CARead the original story w/Photo

    Thursday | Daily Political

    Capital International Inc. CA raised its stake in Illumina, Inc. by 16.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 16,600 shares of the life sciences company's stock after buying an additional 2,300 shares during the period.

    Comment?

  4. Illumina Names New Board MemberRead the original story

    Tuesday Feb 21 | SocalTECH.com

    San Diego-based Illumina announced this morning that it ha added John W. Thompson to the company's board of directors. Thompson previously was CEO of Symantec and Virtual Instruments, and also has served at IBM.

    Comment?

  5. Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care ConferenceRead the original story w/Photo

    Tuesday Feb 21 | Business Wire

    The live webcast is scheduled to begin at 10:00 AM ET and will feature a brief overview of the company by Marc Stapley, Executive Vice President and Chief Administrative Officer, followed by a question and answer session. The webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com .

    Comment?

  6. N-Of-One Dramatically Speeds High-Accuracy Interpretation Of The...Read the original story

    Monday Feb 20 | BioSpace

    ... 2008 as a leader in interpretation of molecular tests in oncology, announced today the launch of RapidInsights for Illumina's TruSight Tumor 170 (TST170). RapidInsights is a fully automated interpretation solution that, in a matter of minutes, will ...

    Comment?

  7. Illumina Names John W. Thompson to Its Board of Directors, Bringing...Read the original story

    Monday Feb 20 | PressReleasePoint

    Feb. 20, 2017-- Illumina, Inc. announced today that John W. Thompson will join the company's Board of Directors on May 3, 2017, bringing extensive technology leadership experience to the company. Mr. Thompson's executive leadership experience includes having served in chief executive officer roles at Symantec and Virtual Instruments, as well as 28 years of prior leadership experience at IBM where he held senior roles in sales, marketing, software development, and as general manager of IBM Americas.

    Comment?

  8. Omead Ostadan Sells 2,173 Shares of Illumina, Inc. (ILMN) StockRead the original story w/Photo

    Friday Feb 17 | IntersportsWire

    Illumina, Inc. EVP Omead Ostadan sold 2,173 shares of Illumina stock in a transaction that occurred on Monday, February 13th. The shares were sold at an average price of $163.10, for a total transaction of $354,416.30.

    Comment?

  9. InVivoScribe Technologies, Inc. Announces Long-Term Collaboration...Read the original story

    Monday Feb 13 | BioSpace

    Invivoscribe Technologies Inc., an international company with decades of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics and personalized molecular medicine , announces today its long-term collaboration agreement with Illumina Inc., to develop and commercialize in vitro diagnostic assays for the next-generation sequencing MiSeqDx platform. This agreement allows Invivoscribe to bring IVD assays through the FDA, together with the associated bioinformatics software, for sale and distribution in the US.

    Comment?

  10. 2.7 million samples genotyped for HLA by next generation sequencing: lessons learnedRead the original story w/Photo

    Monday Feb 13 | BioMed Central

    At the DKMS Life Science Lab, Next Generation Sequencing has been used for ultra-high-volume high-resolution genotyping of HLA loci for the last three and a half years. Here, we report on our experiences in genotyping the HLA, CCR5, ABO, RHD and KIR genes using a direct amplicon sequencing approach on Illumina MiSeq and HiSeq 2500 instruments.

    Comment?

  11. Screening and evaluating of long noncoding RNAs in the puberty of goatsRead the original story w/Photo

    Monday Feb 13 | BioMed Central

    ... by using ethanol precipitation. Then the libraries whith high strand-specificity for sequencing was generated [ ]. Illumina Hiseq 4000 platform was adopted on sequencing and 150 bp paired-end reads were generated. Raw reads were dealt with in-house ...

    Comment?

  12. Messner & Smith Theme Value Investment Management Ltd. CA Has...Read the original story w/Photo

    Tuesday Feb 7 | IntersportsWire

    Complete the form below to receive the latest headlines and analysts' recommendationsfor Illumina Inc. with our free daily email newsletter: Messner & Smith Theme Value Investment Management Ltd. CA reduced its stake in shares of Illumina, Inc. by 4.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 15,390 shares of the life sciences company's stock after selling 752 shares during the period.

    Comment?

  13. Clinical utility of gene panel-based testing for hereditary...Read the original story

    Tuesday Feb 7 | Leukemia

    ... of DNA compared to hair roots and nail clippings. The targeted next-generation sequencing was performed using Illumina technology (San Diego, CA, USA). The high-density exon-targeted array comparative genomic hybridization is custom designed using ...

    Comment?

  14. Cameron's visit to Illumina continues San Diego's British biotech invasionRead the original story w/Photo

    Friday Feb 3 | The San Diego Union-Tribune

    David Cameron , former prime minister of the United Kingdom, visited the San Diego headquarters of DNA sequencing giant Illumina this week. It's the latest example of Britain's interest in San Diego's life science industry at the highest levels.

    Comment?

  15. Illumina (ILMN) Q4 2016 Results - Earnings Call TranscriptRead the original story w/Photo

    Tuesday Jan 31 | Seeking Alpha

    Welcome to the Fourth Quarter 2016 Illumina, Inc. Earnings Conference Call. My name is Sherry and I will be your operator for today's call.

    Comment?

  16. ADAM23 is a common risk gene for canine idiopathic epilepsyRead the original story w/Photo

    Monday Jan 30 | BioMed Central

    ... set (Affymetrix, Santa Clara, CA, USA) with ~50,000 single-nucleotide polymorphism (SNP) markers or with the Illumina Canine HD Bead chips (Illumina, Inc., San Diego, CA, USA) for more than 173,000 SNPs across all canine chromosomes. The samples ...

    Comment?

  17. Illumina Names Board MemberRead the original story

    Monday Jan 30 | SocalTECH.com

    San Diego-based Illumina said it has named Caroline Dorsa to its board of directors, the company said last week. Dorsa was most recently was Executive Vice President and CFO at Public Service Enterprise Group, and served at Merck & Co., as its Senior Vice President of Marketing Stragegy and Integration, and Vice President and Tresasurer, in addition to time at Avaya.

    Comment?

  18. Illumina Debuts VeriSeq Analysis Software (48 Samples), Optimized...Read the original story

    Sunday Jan 29 | BioSpace

    Illumina, Inc. today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeqa NIPT Analysis Software for clinical laboratories in the European Union . This updated VeriSeqa NIPT Analysis Software includes an innovative method for processing samples and is designed for larger batches of 48 samples, versus the current 16 samples, which can scale to meet the future demands of the growing noninvasive prenatal testing market.

    Comment?

  19. Illumina Debuts VeriSeq Analysis Soft ...Read the original story

    Monday Jan 30 | The Financial Mirror

    Illumina, Inc. today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeqa NIPT Analysis Software for clinical laboratories in the European Union . This updated VeriSeqa NIPT Analysis Software includes an innovative method for processing samples and is designed for larger batches of 48 samples, versus the current 16 samples, which can scale to meet the future demands of the growing noninvasive prenatal testing market.

    Comment?

  20. Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over...Read the original story w/Photo

    Friday Jan 27 | Business Wire

    )--Illumina, Inc. (NASDAQ: ILMN) announced today that Caroline Dorsa has joined the company's Board of Directors. Given her financial expertise, Ms. Dorsa will also participate on the Audit Committee of the Board. Ms. Dorsa has held a number of ...

    Comment?